Genscript Biotech Corp

01548

Company Profile

  • Business description

    GenScript Biotech Corp is an investment holding company engaged in the manufacture and sale of life science research products and services, including life science services and products, biologics development services, and industrial synthetic biology products. Its segments include life science services and products, which generate maximum revenue and provide research services and products; biologics development services, which support the development of therapeutic antibodies and CGT products; industrial synthetic biology, which provides enzyme development and production using engineered microbial strains; and the operation unit, which provides shared services. It operates in Mainland China, which generates maximum revenue, U.S., Europe, and the Asia Pacific excluding Mainland China.

  • Contact

    860 Centennial Avenue
    PiscatawayNJ08854
    USA

    https://www.genscript.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    6,165

Stocks News & Analysis

stocks

Chart of the Week: Recent selloffs in this ASX sector opens doors to opportunity

Ongoing rate hikes have investors spooked.
stocks

ASX dividend champions: Stocks, ETFs and LICs

Mark and Shani run through lessons for ASX stocks, ETFs and LICs that have delivered over the past decade.
stocks

SpaceX’s IPO filing: Big spending, big losses

The first public financials from Elon Musk’s company highlight Starlink’s revenue power and increased spending on AI.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,856.306.000.07%
CAC 408,117.42135.661.70%
DAX 4024,737.24336.591.38%
Dow JONES (US)50,009.35645.471.31%
FTSE 10010,432.34101.790.99%
HKSE25,620.5830.54-0.12%
NASDAQ26,270.36399.651.54%
Nikkei 22561,945.342,140.933.58%
NZX 50 Index12,803.4142.380.33%
S&P 5007,432.9779.361.08%
S&P/ASX 2008,635.507.500.09%
SSE Composite Index4,174.7912.610.30%

Market Movers